Gm3 Synthase Deficiency C1836824
GM3 Synthase Deficiency is a rare inherited disorder affecting how the body processes certain fats called gangliosides, crucial for brain function. It typically appears in infancy and causes severe developmental delays, seizures, and movement problems. Treatment focuses on managing symptoms and supporting development.
Key facts at a glance
- ICD-10
- G31.82
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe developmental delay
Generalized tonic-clonic seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Dystonia
(neurologic)Visual impairment
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Seizure management
Comprehensive anticonvulsant therapy tailored to seizure types observed in GM3 synthase deficiency, with regular neurological follow-up for medication adjustment.
Developmental and neurological surveillance
Regular developmental assessments and neurological monitoring to track disease progression and identify emerging complications requiring intervention.
Additional treatment options
Early intervention physical therapy
Age-appropriate therapeutic activities to support motor development, maintain joint mobility, and maximize functional potential.
physical_therapyNutrition management
Assessment and support for adequate nutrition, potentially including specialized formulas or feeding methods if oral intake is compromised.
dietaryNeurodevelopmental support
Cognitive and behavioral support services addressing developmental delays, sensory processing issues, and behavioral challenges associated with the condition.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Gm3 Synthase Deficiency C1836824?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Gm3 Synthase Deficiency C1836824. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy